메뉴 건너뛰기
Journal of Neuropathology and Experimental Neurology
Volumn 64, Issue 8, 2005, Pages 741-
Complement as a biomarker in multiple sclerosis
Author keywords

[No Author keywords available]
Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT; MYELIN;
EID: 23844453347     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000175643.57245.08     Document Type: Letter
Times cited : (8)
References (3)
  • 1
    • 0002988424 scopus 로고    scopus 로고
    • The complement system in demyelinating disease: New insights from transgenic and complement-deficient mice
    • Bondy SC, Campbell A, eds.
    • Barnum SR. The complement system in demyelinating disease: New insights from transgenic and complement-deficient mice. In: Bondy SC, Campbell A, eds. Inflammatory Events in Neurodegeneration. Scottsdale: Prominent Press, 2001:139-56
    • (2001) Inflammatory Events in Neurodegeneration. Scottsdale: Prominent Press , pp. 139-156
    • Barnum, S.R.1
  • 2
    • 0342906187 scopus 로고    scopus 로고
    • Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
    • Lucchinetti C, Bruck W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 2000;47:707-17
    • (2000) Ann Neurol , vol.47 , pp. 707-717
    • Lucchinetti, C.1    Bruck, W.2    Parisi, J.3
  • 3
    • 14844293538 scopus 로고    scopus 로고
    • The pathology of multiple sclerosis is location-dependent: No significant complement activation is detected in purely cortical lesions
    • Brink BP, Veerhuis R, Breij EC, et al. The pathology of multiple sclerosis is location-dependent: No significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005;64:147-55
    • (2005) J Neuropathol Exp Neurol , vol.64 , pp. 147-155
    • Brink, B.P.1    Veerhuis, R.2    Breij, E.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.